| David Grossman, | |
|
44201 Dequindre Rd, Troy, MI 48085-1117 | |
| (248) 964-4100 | |
| Not Available |
| Full Name | David Grossman |
|---|---|
| Gender | Male |
| Speciality | Pathology - Anatomic Pathology & Clinical Pathology |
| Location | 44201 Dequindre Rd, Troy, Michigan |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1831159920 | NPI | - | NPPES |
| 4262085 | Medicaid | MI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 4301404919 (Michigan) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| David Grossman, 3601 W 13 Mile Rd, 400-fsc/pcs, Royal Oak, MI 48073-6712 Ph: () - | David Grossman, 44201 Dequindre Rd, Troy, MI 48085-1117 Ph: (248) 964-4100 |
News Archive
Nursing homes are still taking days to get back COVID-19 test results as many shun the Trump administration's central strategy to limit the spread of the virus among old and sick Americans.
Silicon Biosystems, S.p.A., a provider of specialized molecular and cell biology technology, today announced that it has formed a U.S. subsidiary operation, Silicon Biosystems, Inc., to be headquartered in San Diego, California. The newly formed business will focus on commercial operations and the development of the North American research and clinical diagnostics markets for the company's DEPArray™ technology platform.
Merck's HPV vaccine Gardasil and GlaxoSmithKline's HPV vaccine Cervarix in clinical trials have been shown to be 100% effective in preventing infection with HPV strains 16 and 18, which together cause about 70% of cervical cancer cases.
Novartis announced today that the United States Food and Drug Administration has granted Breakthrough Therapy designation to PKC412 (midostaurin). PKC412 (midostaurin) is an investigational treatment for adults with newly-diagnosed AML who are FLT3 mutation-positive, as detected by an FDA-approved test, and who are eligible to receive standard induction and consolidation chemotherapy.
› Verified 4 days ago
Hongwei Ma, Pathology Medicare: Not Enrolled in Medicare Practice Location: 44201 Dequindre Rd, Troy, MI 48085 Phone: 248-964-4100 | |
Dr. Kinda Hayek, Pathology Medicare: Not Enrolled in Medicare Practice Location: 500 Kirts Blvd, Troy, MI 48084 Phone: 855-422-5179 | |
Xia Chen, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 44201 Dequindre Rd, Troy, MI 48085 Phone: 248-964-4130 Fax: 248-964-8010 | |
Dr. Thomas Owen Robbins, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 2540 Timberwyck Trail Dr, Troy, MI 48098 Phone: 248-840-6563 | |
Lei Lei Chen, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 44201 Dequindre Rd, Troy, MI 48085 Phone: 248-964-4130 Fax: 248-964-8010 | |
Charles Eugene Smart, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 2811 Charter Dr, #206, Troy, MI 48083 Phone: 248-312-8193 | |
Ralph Zade, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 44201 Dequindre, Troy, MI 48085 Phone: 248-898-5000 |